Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Carbocisteine may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for 2. What you need to know before you take Carbocisteine oral solution in sachet 3. How to take Carbocisteine oral solution in sachet 4. Possible side effects 5. How to store Carbocisteine oral solution in sachet 6. Contents of the pack and other information
1. What Carbocisteine oral solution in sachet is and what it is used for This medicine belongs to a group of medicines called "mucolytics". It works by making mucus (phlegm) less sticky. This makes the mucus easier to cough up. This medicine is used for problems with the breathing passages (respiratory tract). This medicine is indicated in adults and children over 15 years.
e Carbocisteine oral solution in sachet Do not take Carbocisteine oral solution in sachet:
Precautions for use This medicine should always be accompanied by voluntary efforts to cough, which help expectoration. Do not take cough medicine (to stop coughing) or medicine that dries out bronchial secretions during the treatment period with carbocisteine. CONSULT A DOCTOR IF NO IMPROVEMENT IS SEEN. Other medicines and Carbocisteine oral solution in sachet Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, even if it is medication obtained without a prescription. This medicine contains carbocisteine. Other medications also contain carbocisteine. Please do not take them at the same time in order to avoid exceeding the maximum doses advised (see 3. HOW TO TAKE Carbocisteine oral solution in sachet ) Pregnancy and breast-feeding Carbocisteine is not recommended during pregnancy or breast-feeding. Talk to your doctor before taking this medicine if:
ULM packaging code
+ Quiet area for datamatrix
Carbocisteine
xxxxxx
20 datamatrix control code = plant packaging code
Package leaflet: Information for the user
When in doubt, please ask your doctor or pharmacist.
Carbocisteine oral solution in sachet Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Mode of administration Oral route. FOR ADULTS AND CHILDREN OVER 15 YEARS ONLY Do not use this medicine in children under 15 years. Posology The standard dose is 750 mg of carbocisteine 3 times a day, or one 10 ml sachet 3 times a day. If your symptoms improve, your dose may be lowered to 2 sachets per day (taken separately). This medicine is appropriate for patients following a low sugar or low calorie diet. If you feel that the effects of Carbocisteine oral solution in sachet are too strong or not strong enough, please talk to your doctor or pharmacist. If symptoms (cough) persist, consult your doctor. If you take more Carbocisteine oral solution in sachet than you should: Contact your doctor or go to a hospital casualty department straight away. Take the medicine pack with you. This is so the doctor knows what you have taken. If you take too much, it is likely that you will get an upset stomach (gastrointestinal disturbance). If you forget to take Carbocisteine oral solution in sachet: Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects Like all medicines, Carbocisteine oral solution in sachet can cause side effects, although not everybody gets them. Stop taking Carbocisteine oral solution and see a doctor or go to a hospital straight away if:
Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report
directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Quiet area in backing of
By reporting side effects you can help provide more information on the safety of this medicine.
Carbocisteine oral solution in sachet Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month. Do not store above 25°C. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Carbocisteine oral solution in sachet contains The active substance is carbocisteine. Each 10 ml oral solution contains 750 mg of carbocisteine. The other ingredients are: Saccharin sodium, sodium methyl para-hydroxybenzoate (E 219), hydroxyethylcellulose, caramel/vanilla flavouring (contains alcohol), sorbitol liquid (non-crystallising), maltitol liquid, sodium hydroxide*, purified water.
xxxxxx
This medicine contains small quantities of ethanol (alcohol), less than 100 mg per sachet.
Carbocisteine 750mg/10ml sugar-free oral solution in sachet comes as oral solution containing 750mg / 10ml. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Carbocisteine 750mg/10ml sugar-free oral solution in sachet is carbocisteine.
This leaflet reproduces the patient information leaflet approved for Carbocisteine 750mg/10ml sugar-free oral solution in sachet, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
This medicine is indicated in adults and children over 15 years for the adjunctive therapy of respiratory tract disorders characterised by excessive, viscous mucus, including chronic obstructive airways disease.
FOR ADULTS AND CHILDREN OVER 15 YEARS ONLY
Oral route.
One 10 ml sachet contains 750 mg of carbocisteine.
The standard dose is 750 mg, 3 times a day (i.e. 2250mg), or 1 sachet, 3 times a day. The dose should be reduced to 1500mg daily in divided doses when a satisfactory response is obtained i.e. dose reduction from 3 sachets per day to 2 sachets per day (taken separately).
This medicine is appropriate for patients following a low sugar or low calorie diet.
Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1.
Active peptic ulceration
Special warning
Productive coughs that represent a fundamental element in bronchial-pulmonary defences should be respected.
The association of bronchial mucous modifiers with anti-cough medicines and/or substances that dry out secretions (atropinic) is not rational.
This medicine contains sodium methyl para-hydroxybenzoate (E219) and can cause allergic reactions (sometimes late onset).
This medicine contains maltitol and sorbitol. It is not recommended for fructose-intolerant patients (rare hereditary disease).
This medicine contains small amounts of ethanol (alcohol), less than 100 mg per sachet.
This medicine contains sodium. This medicine contains 97.5 mg (4.24 mmol) of sodium per dose.
This should be taken into account in patients following strict low sodium diets.
Precautions for use
Caution is recommended in the elderly, in those with a history of gastroduodenal ulcers, or those taking concomitant medications known to cause gastrointestinal bleeding. Since mucolytics may disrupt the gastric mucosal barrier, caution should be taken in patients with a history of peptic ulcers. If gastrointestinal bleeding occurs, patients should discontinue medication.
The combination of mucolytics with antitussives and/or substances that dry out secretions (atropinic) is not rational.
Pregnancy
There are no available data on carbocisteine use in pregnant women. No conclusions can be drawn regarding whether or not carbocisteine is safe for use during pregnancy. The use of carbocisteine in pregnant women is not recommended, especially during the first trimester.
Breast-feeding
There are no available data on the presence of carbocisteine in human milk, milk production, or the effects on the breastfed infant. No conclusions can be drawn regarding whether or not carbocisteine is safe for use during breastfeeding. The use of carbocisteine in breastfeeding women is not recommended.
The medicinal product has negligible influence on the ability to drive and use machines.
Immune system disorders
There have been reports of anaphylactic reactions, allergic skin eruption and fixed drug eruption.
Gastrointestinal disorders
There have been reports of diarrhoea, nausea, epigastric discomfort and gastrointestinal bleeding occurring during treatment with carbocisteine.
Frequency not known: vomiting, gastrointestinal bleeding.
Skin and subcutaneous tissue disorders
There have been reports of skin rashes and allergic skin eruptions. Isolated cases of dermatitis bullous such as Stevens-Johnson syndrome and erythema multiforme have also been reported.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Gastric lavage may be beneficial, followed by observation. Gastrointestinal disorders is the most likely symptom of overdosage. In such cases, it is advised to reduce the dosage.
Medicines sold in Romania with the same active substance: Cunoscut în România ca
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
Medicines sold in Poland with the same active substance: W Polsce znany jako
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Carbocisteine 750mg/10ml sugar-free oral solution in sachet. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.